MTOR and osteosarcoma: Since previous studies using mTOR inhibitors showed differential inhibitory effects on the in vivo growth of different osteosarcoma cell lines23, 24, 25, 26, we examined whether mTOR inactivation alone would cause loss of tumorigenicity in SSEA-4+ TICs and their progeny by enforcing terminal differentiation in vivo.